Key Finding
Nearly 57% of patients with perianal fistulizing Crohn's disease experience depression, with disease severity, quality of life, fatigue levels, and fistula complexity identified as independent risk factors.
Researchers studied depression rates among people with perianal fistulizing Crohn's disease (PFCD), a painful complication where abnormal tunnels form near the anus. This condition causes significant physical and emotional distress, but little research has examined mental health impacts. The study surveyed 123 PFCD patients in China, using questionnaires to measure depression symptoms, quality of life, and fatigue levels. They also collected medical information about disease severity and perianal condition. The findings were striking: nearly 57% of patients experienced depression—a rate much higher than the general population. Several factors increased depression risk: more severe perianal disease activity, worse quality of life scores, greater fatigue, and more complex fistula patterns on imaging. Patients with more active perianal disease and lower quality of life also experienced more severe depression symptoms. This research highlights that depression is extremely common in PFCD patients and directly relates to disease severity and daily functioning. For patients considering complementary approaches like acupuncture, this study emphasizes the importance of addressing both physical and mental health aspects of inflammatory bowel disease. Acupuncture has been studied for managing depression, chronic pain, and inflammatory conditions, and may offer supportive care for PFCD patients dealing with these overlapping challenges. When seeking acupuncture treatment, always work with a licensed acupuncturist experienced in treating gastrointestinal conditions and who can coordinate care with your gastroenterologist.
This cross-sectional study examined depression prevalence and associated risk factors in 123 patients with perianal fistulizing Crohn's disease (PFCD). Using validated instruments including PHQ-9, IBDQ, and IBD Fatigue Scale, researchers found 56.91% of patients exhibited depressive symptoms. Multivariate logistic regression identified four independent risk factors for depression: PDAI score (OR=0.69, 95%CI: 0.50-0.95), IBDQ score (OR=0.93, 95%CI: 0.88-0.97), modified Van Assche index (OR=1.24, 95%CI: 1.01-1.53), and IBD Fatigue score (OR=1.72, 95%CI: 1.23-2.42). Multiple linear regression demonstrated that higher Van Assche index scores (β=0.166) and lower IBDQ scores (β=-0.116) independently correlated with depression severity. Clinical implications: PFCD patients require integrated mental health screening and management. Acupuncture practitioners treating this population should assess for depression, coordinate with gastroenterology and mental health providers, and recognize that perianal disease severity, quality of life impairment, and fatigue are key depression indicators requiring comprehensive treatment approaches.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Home-based TEAS reduced depression scores from moderate (PHQ-9: 13.9-14.2) to mild levels (PHQ-9: 6.5-7.7) in IBD patients, with high acceptability and adherence rates when delivered via smartphone app guidance.
📌 Depression significantly increases the risk of poor outcomes in IBD patients, including 37% higher flare risk and 38% increased likelihood of surgery or medication escalation.
📌 Inflammation in IBD activates the tryptophan-kynurenine metabolic pathway, producing neuroactive metabolites that directly link intestinal inflammation to depression through the gut-brain axis.